Dr. Fraser-Liggett Reports on Impact of Genomics on Personalized Medicine
University of Maryland School of Medicine
The Tech Council of Maryland heard a detailed report on the Impact of Genomics on Personalized Medicine at their meeting Dec. 7 from Claire Fraser-Liggett, PhD, director of the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine. She cited advances being made in technology and research and concluded with issues to be considered in the future.
Fraser-Liggett is a renowned researcher in the rapidly evolving field of microbial genomics and leads a team of IGS investigators applying large-scale DNA sequencing and analysis to the study of the microbial world to address challenges in disease research, bioterrorism, environmental issues and other areas. Their innovative work is creating a paradigm shift in the study of microorganisms and how microbes impact human health.
She began with a review of genomic research and an update on rapid advances in technology that are making new research more affordable.
The Tech Council event was held at the University of Maryland BioPark.
The Impact of Genomics on Personalized Medicine BioBreakfast was sponsored by BioMarker Strategies, Cylex, DynPort Vaccine Company, Emergent BioSolutions, Howard Consulting Group, Inc., Johns Hopkins University, Novavax, Paragon BioServices, Inc., Psyadon Pharmaceuticals, Inc., QIAGEN, University of Maryland BioPark, and VWR International.
Posting Date: 12/09/2010
Contact Name: Ed Fishel
Contact Phone: 410-706-3801
Contact Email: efishel@umaryland.edu
UMB News
No hay comentarios:
Publicar un comentario